what dose of retatrutide should i take Dosage: Week-to-Week Schedule & Chart VisualAbstract: Retatrutide reduces body weight

Over 95% of individuals have reported minimal to no side effects while taking GLP-1 medications

GLP-1 receptor agonists are a class of medications that mimic the glucagon-like peptide-1 hormone, enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying to lower blood glucose levels

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management and chronic weight management, is administered subcutaneouslymeaning the needle penetrates through the skin into the fatty tissue layer beneath

6,7,8,9,10,16 Indeed, GLP-1 receptor (GLP-1R) agonists, such as liraglutide and semaglutide, are approved for the treatment of both type 2 diabetes (T2D) and obesity

Propensity score matching using 48 variables was conducted to match a group of adults prescribed tirzepatide, 1:1, with those prescribed a GLP-1

Gut 65 , 702711 (2016)